News & Events
Webinar | May 16, 2023 | 8:00am PST / 11:00am EST
Using Machine Learning to Find Potential Lead Molecules
Join us at this dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Hear presentations on targeting transcription factors, plus greatly expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery.
Podcast | May 25, 2023
Catalyzing Drug Discovery with AI and Scaled Chemical Libraries with a Cayer
In this podcast, Axial VC founder Joshua Elkington talks with Devon Cayer, 1859’s cofounder and company leader, about Devon’s inspirations, motivations, and innovations that set his trajectory as an entrepreneur and Founder of 1859. The underlying technology of 1859 relies on Devon’s and his co-founders’ expertise in combinatorial library preparation, pico-scale activity-based screening to create SAR models for each compound, and machine learning of iterative screens of titrated compounds to predict the best leads.